• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9755RSL29A
Device Problem Material Deformation (2976)
Patient Problem Perforation of Vessels (2135)
Event Date 10/05/2023
Event Type  Injury  
Event Description
During a tavr procedure using a 29mm sapien 3 resilia valve via transfemoral approach, the delivery system (ds) was unable to advance with valve through the iliac.The implanter was able to remove first valve without complication and tried to make adjustments to improve the chances to advance the second valve through the iliac but was not able to advance.During the attempt to remove the second valve and delivery system from patient, the valve strut poked out of the sheath and tore the right external iliac and got stuck in the common femoral and it could not be removed from the patient.As a result, a vascular surgeon was called and had to surgically remove the valve from the patient and perform a fem/fem bypass.The surgery was a success and patient was removed from room and transported to icu.
 
Manufacturer Narrative
The investigation is ongoing.Voluntary medsun number: (b)(4).
 
Manufacturer Narrative
Correction to h6; type of investigation, investigation findings, investigation conclusion.This is one of three manufacturer reports being submitted for this case.Please reference related manufacturer report no: 2015691-2023-17497 and 2015691-2023-17187.The event reported is anticipated in the risk management documentation for transcatheter heart valve procedures.A previous investigation into this type of event is captured in an edwards lifesciences technical summary and applies to this complaint.Additional assessment of the failure mode is not required at this time.The 29mm sapien 3 reslia valve was returned for examination.A visual examination found two bent struts on the inflow side, the two struts were exposed through the skirt, the frame was distorted/canted, and the leaflets were dehydrated and wrinkled due to storage conditions (prolonged crimping) during the return handling process.Functional and dimensional testing could not be performed due to the nature of the complaint.Per the technical summary, the ifu, current risk mitigations include design and manufacturing controls, and training manuals have been reviewed, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.In this case, the complaint for frame damage was confirmed based on the evaluation of the returned device.Available information suggests procedural factors (excessive manipulation/high push force) likely contributed to the event as two struts on the inflow side were observed to be bent.Excessive device manipulation or high push force can lead to the valve struts interacting with the sheath shaft and result in strut damage at the valve inflow side.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.A previous product risk assessment was initiated to capture this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18046686
MDR Text Key327049934
Report Number2015691-2023-17182
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103215823
UDI-Public(01)00690103215823(17)260521(11)2305222110698730
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9755RSL29A
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/06/2023
Initial Date FDA Received11/01/2023
Supplement Dates Manufacturer Received12/21/2023
Supplement Dates FDA Received12/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/16/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexMale
Patient Weight74 KG
-
-